Nectar Lifesciences Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
16,335
16,429
16,757
16,440
18,767
Cost of Goods Sold (COGS) incl. D&A
13,884
13,960
14,397
14,147
15,097
Gross Income
2,450
2,469
2,360
2,292
3,670
SG&A Expense
394
573
532
652
1,947
EBIT
2,040
1,896
-
1,638
1,723
Unusual Expense
-
-
-
144
-
Non Operating Income/Expense
6
49
12
2
56
Interest Expense
1,380
1,256
1,233
1,174
1,152
Pretax Income
782
848
638
674
627
Income Tax
161
185
96
121
104
Consolidated Net Income
621
663
542
553
523
Net Income
621
663
542
553
523
Net Income After Extraordinaries
621
663
542
553
523
Net Income Available to Common
621
663
542
553
523
EPS (Basic)
2.77
2.95
2.42
2.47
2.33
Basic Shares Outstanding
224
224
224
224
-
EPS (Diluted)
2.77
2.95
2.42
2.47
-
Diluted Shares Outstanding
224
224
224
224
-
EBITDA
2,882
2,662
2,400
2,261
2,366
Other Operating Expense
16
-
1
2
-
Non-Operating Interest Income
116
158
56
68
-
About Nectar Lifesciences
View Profile
